A double-blind, placebo-controlled, proof-of-concept clinical study assessing the effect of ACP-103 on deep, or slow wave, sleep in healthy older volunteers.

Trial Profile

A double-blind, placebo-controlled, proof-of-concept clinical study assessing the effect of ACP-103 on deep, or slow wave, sleep in healthy older volunteers.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 May 2016

At a glance

  • Drugs Pimavanserin (Primary)
  • Indications Insomnia
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 06 May 2016 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top